西点药业：2025年半年度净利润约2494万元，同比增加2.02%

Group 1 - The core viewpoint of the article is that West Point Pharmaceutical reported its semi-annual performance, showing a slight decline in revenue but an increase in net profit and earnings per share [2] Group 2 - For the first half of 2025, the company's operating revenue was approximately 128 million yuan, a year-on-year decrease of 0.51% [2] - The net profit attributable to shareholders of the listed company was approximately 24.94 million yuan, reflecting a year-on-year increase of 2.02% [2] - The basic earnings per share were 0.3261 yuan, which represents a year-on-year increase of 7.77% [2]